FY2025 · ended Dec 31, 2025 · Revenue $822.31M, +2.9% YoY · Filed Feb 24, 2026
Orthofix Medical Inc. (OFIX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $822.3 million and a net loss of $92.2 million. Free cash flow was -$1.3 million. As of Jun 30, 2026 it held $103.8 million in cash and investments and $261.9 million in total debt.
Revenue (TTM)
$833.19M
+3.0% vs year-ago TTM
Net income (TTM)
$-61.72M
+50.1% vs year-ago TTM
Operating cash flow (TTM)
$16.27M
-43.2% vs year-ago TTM
Free cash flow (TTM)
$-27.82M
-6135.6% vs year-ago TTM
EPS (TTM)
$-1.53
+51.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
40.14M
+2.9% vs prior year
Net cash
$-158.09M
as of Jun 30, 2026
Operating margin
-4.7%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- OFIX (Nasdaq)
- Fiscal year ends
- December 23
- Headquarters
- Lewisville, TX
- SEC filer status
- Accelerated filer
- SEC CIK
- 884624
- Former names
- ORTHOFIX INTERNATIONAL N V (until Aug 1, 2018)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $822.3M | $799.5M | $746.6M | $460.7M | $464.5M |
| Operating income | -$81.4M | -$84.6M | -$139.1M | -$13.3M | -$8.3M |
| Net income | -$92.2M | -$126.0M | -$151.4M | -$19.7M | -$38.4M |
| Diluted EPS | -$2.33 | -$3.30 | -$4.12 | -$0.98 | -$1.95 |
| Operating cash flow | $33.3M | $25.8M | -$45.8M | -$11.5M | $18.5M |
| Free cash flow | -$1.3M | -$9.1M | -$106.0M | -$32.9M | $690,000 |
| Total assets | $850.6M | $893.3M | $925.3M | $458.6M | $476.6M |
| Total liabilities | $400.6M | $390.2M | $326.6M | $121.8M | $139.7M |
| Stockholders' equity | $450.0M | $503.1M | $598.7M | $336.9M | $336.9M |
| Cash and investments | $82.0M | $83.2M | $33.1M | $50.7M | $87.8M |
| Total debt | $203.8M | $193.0M | $134.2M | $26.9M | $23.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 2, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 21, 2026 | May 21, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
All 1007 Orthofix Medical Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.